The departments of Health and Human Services and Defense yesterday announced an $11.6 million contract to domestically produce more nasal swabs for the Cue Health molecular testing system, which detects the COVID-19 virus in about 20 minutes at the point of care.

The contract will allow Puritan Medical Products Company to expand domestic production capacity to 3 million per month by March 2021, the agencies said. HHS recently distributed 27,000 Cue Health test kits to Alaska, Florida, Louisiana, New Jersey and Texas for a pilot test. The Food and Drug Administration has authorized emergency use of the testing system in patient care settings operating under a CLIA certificate of waiver, compliance or accreditation.

Related News Articles

Headline
The Food and Drug Administration today issued a request for public comment on a series of questions regarding current approaches to evaluating artificial…
Headline
The Food and Drug Administration yesterday announced that Olympus issued a global recall of its ViziShot 2 FLEX needles manufactured prior to May 12 following…
Headline
The Advisory Committee on Immunization Practices Sept. 19 recommended that patients should consult their health care provider if they want to receive a COVID-…
Headline
The Department of Health and Human Services Sept. 18 announced it will take new actions to help improve care for individuals with long COVID. They include a…
Headline
The Food and Drug Administration has identified a Class I recall for Mo-Vis BVBA R-net Joysticks due to a firmware error that causes the wheelchair to ignore…
Headline
The Centers for Disease Control and Prevention is predicting a similar combined number of peak hospitalizations from COVID-19, the flu and respiratory…